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Abstract: In recent years, great interest has been paid to the development of compounds 
with high selectivity for central dopamine (DA) D3 receptors, an interesting therapeutic 
target in the treatment of different neurological disorders. In the present work, based on a 
dataset of 110 collected benzazepine (BAZ) DA D3 antagonists with diverse kinds of 
structures, a variety of in silico modeling approaches, including comparative molecular 
field analysis (CoMFA), comparative similarity indices analysis (CoMSIA), homology 
modeling, molecular docking and molecular dynamics (MD) were carried out to reveal the 
requisite 3D structural features for activity. Our results show that both the receptor-based  
(Q
2 = 0.603, R
2
ncv = 0.829, R
2
pre = 0.690, SEE = 0.316, SEP = 0.406) and ligand-based  
3D-QSAR models (Q
2 = 0.506, R
2
ncv =0.838, R
2
pre = 0.794, SEE = 0.316, SEP = 0.296) are 
reliable with proper predictive capacity. In addition, a combined analysis between the 
CoMFA, CoMSIA contour maps and MD results with a homology DA receptor model 
shows that: (1) ring-A, position-2 and R3 substituent in ring-D are crucial in the design of 
antagonists with higher activity; (2) more bulky R1 substituents (at position-2 of ring-A) of 
antagonists may well fit in the binding pocket; (3) hydrophobicity represented by MlogP is 
important for building satisfactory QSAR models; (4) key amino acids of the binding 
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pocket are  CYS101, ILE105, LEU106, VAL151, PHE175, PHE184, PRO254 and 
ALA251. To our best knowledge, this work is the first report on 3D-QSAR modeling of 
the new fused BAZs as DA D3 antagonists. These results might provide information for a 
better understanding of the mechanism of antagonism and thus be helpful in designing new 
potent DA D3 antagonists. 
Keywords: 3D-QSAR; dopamine D3 receptor; antagonist; CoMFA; CoMSIA 
 
1. Introduction  
Being phylogenetically classified as a member of the biogenic amine receptors, DA receptors 
belong to a large, “rhodopsin-like” subfamily of G-protein-coupled receptors (GPCRs) [1]. In this 
family, two DA receptor subfamilies named D1- and D2-like receptors exist, the latter of which 
consists of D2, D3 and D4 subtypes. Both subfamilies couple to GPCRs and inhibit the adenylyl 
cyclase [1]; however, each subtype mediates different actions of dopamine, such as the dopamine D1 
and D2 receptors, which were purported to possess unequal biochemical and pharmacological 
properties and mediate different physiological functions [1]. Out of all D2-like receptors, more 
attention is now paid to the dopamine D3 receptors due to their critical role identified in the control of 
movement [1]. Actually ever since 1990 when the cDNA of DA D3 receptor was first isolated and 
characterized by Schwartz and co-workers [2], this receptor has attracted much attention due to its 
antipsychotic activity [3] with a wide body of evidence suggesting its potency in the treatment of 
schizophrenia and Parkinson’s disease [4]. DA D3 receptor may also be involved in drug dependence 
and addiction [5]. Hence, due to the diversity of physiological effects, as well as the intimate 
association with a variety of neuropathological diseases, brain disorders and drug addiction, its 
specific function and moderate stimulation or depression by antagonists is always quite an active field 
of scientific and industrial research.  
In 2000, a series of DA agonists including quinpirole, quinelo-rane and   
7-hydroxy-dipropylaminotetralin developed by Wood et al. showed a good correlation between their 
DA D3 agonist capability and their potency to decrease the cocaine self-administration in rats, 
suggesting that these agonists mimic or substitute the effects of cocaine [6]. Besides, some selective 
D3 receptor ligands also reduced the reinforcing efficacy of drugs abuse, and exhibited efficacy in 
animal models of schizophrenia [7]. The discovery of this possible disease treatment with certain D3 
receptor inhibitors has, certainly, aroused another surge of developing preferential D3 partial agonists 
and antagonists including their analogs [1]. In the field of dopamine D3 receptor antagonists, 
numerous developments have been observed during the last decade, and possible commonalities in the 
overall chemical template have been identified among different classes of DA D3 receptor antagonists. 
Three distinct regions have been typically explored: an aromatic region, a hydrogen bond acceptor 
region (HBA), and a basic moiety (Figure 1A) [8]. Most of the modifications have been performed on 
these three regions in order to synthesize novel and more selective D3 antagonists, such as BP897 [6], 
FAUC346 [9] and SB277011A [10] (Figure 1B–D). However, it is observed that the activity of these 
derivatives is very sensitive to a slight modification in specific substituents’ positions, which may span Int. J. Mol. Sci. 2011, 12               
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from neutral D3 antagonism to modulator activity or partial agonism [8]. Therefore, the exploration of 
the relationship between the antagonist activity and different structural modifications in the basic 
structure (Figure 1) of DA D3 receptor ligands is still requisite. 
Figure 1. Structures of FAUC346 (B), BP897 (C) and SB277011A (D), with a basic 
structure of DA D3 receptor antagonists as (A) [8–10]. 
 
Presently, starting from SB277011A, a series of new fused benzazepine (BAZ) derivatives were 
synthesized, with 11 diverse kinds of structures including skeleton types A–K (shown in Tables S1-S3, 
supplementary materials) [7,11]. They attract our research interests not only because they are all DA 
D3 receptor antagonists, but also due to the fact that their antagonist properties to D3   
receptor exhibited a 100-fold selectivity versus dopamine D2 and histamine H1 receptors   
(functional assays) [11]. Thus, it is very promising that they are being developed as new potent 
selective DA D3/D2 antagonists. In molecular structures, compared with the BP897 and FAUC346 
(Figure 1), these new groups of DA D3 receptor antagonists not only possess different Part 4 basic 
structures but also all have a five-heterocyclic substituent in the aromatic ring (Part 1). To our best 
knowledge, this series of BAZ is until now the largest dataset (containing 110 compounds) of new 
fused BAZ-like DA D3 receptor antagonists.  
Time consuming and resource costly as the drug discovery and development process is, there is an 
ever growing effort to apply computational power to the combined chemical and biological space in 
order to streamline drug discovery, design, development and optimization [12]. Quantitative   
structure–activity relationships (QSARs), especially the three-dimensional (3D-) QSAR, as one of the 
computational chemistry areas have been applied widely throughout the world to prioritize untested 
chemicals for more intensive and costly experimental evaluations [13], which methodologies are also 
successfully attempted in our previous studies on estrogen receptor subtype binding affinity [14] 
hepatitis C virus [15], CYP2D6 enzyme inhibitors [16], Catechol-O-methyltransferase inhibitors [17] 
and microRNA-target interaction [18]. The in silico studies on DA receptors have also, up to now, 
achieved some success. For example: DA D3 receptor ligands (FAUC 365 analogues) were studied by 
using Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices 
Analysis (CoMSIA) [4], where only CoMFA and CoMSIA methods were adopted and the whole 
dataset contained just 47 compounds [4]. To reveal the role of QSAR in DA receptors and antagonist 
interaction, another group studied 22 individual datasets including DA D(2), D(3) and D(4) receptors, Int. J. Mol. Sci. 2011, 12               
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with each dataset containing less than 25 compounds. Finally they found that hydrophobicity is the 
most important factor in the interactions [19].  
The aim of the present study is to use the above mentioned 110 new fused BAZ-like compounds as 
data set to identify their requisite structural features affecting the dopamine D3 receptor antagonist 
effects by a combination of several in silico approaches. Compared with the above two in silico 
studies, this dataset is not only larger but also contains a different Part 1 and Part 4 basic structure 
from the former studies. For comparison, both ligand-based and receptor-based QSAR studies, using 
CoMFA, CoMSIA and molecular docking methods, were carried out. As far as we know, this study 
provides the first 3D-QSAR study for these new series of DA D3 receptor antagonists.  
2. Results and Discussion  
2.1. CoMFA and CoMSIA Statistical Results 
It is known that an appropriate superimposition of the molecules being studied within a   
three-dimensional fixed lattice is the key procedure for further CoMFA and CoMSIA studies [20], thus 
much effort has been paid to the ligand-based alignment procedure. Firstly, in an attempt to explore the 
best common substructure for the molecular alignment, we tried three different substructures in 
building the CoMFA and CoMSIA models (Figure 2), using the same training and test sets employed 
in all models. During this process, the partial atomic charges of all compounds were calculated by the 
Gasteiger-Huckel method [21]. Table 1 summarizes the statistical results of the models based on three 
common structure alignments. Clearly, it is observed that models with common substructure C are best.  
Figure 2. Molecular alignment of compounds in the whole dataset. (A), (B) and (C): three 
different common substructures of the molecules employed for molecule alignment which 
are shown in red based on template compound 9; (a), (b) and (c): the ligand-based 
alignments of all compounds in the dataset based on three different common substructures. 
Different colors represent different kind of atoms: white for C, blue for N, red for O, green 
for F, yellow for S and cyan for H, respectively. All the colors in following figures have 
the same meanings. 
 Int. J. Mol. Sci. 2011, 12               
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Table 1. Summary of CoMFA and CoMSIA results based on three different common 
substructures. 
PLS 
Statistics 
A B  C 
CoMFA CoMSIA CoMFA CoMSIA  CoMFA  CoMSIA 
Q
2  0.371  0.404  0.364  0.373  0.506 0.511 
R
2
ncv  0.805  0.780  0.815  0.780  0.838 0.819 
SEE  0.346 0.366  0.338 0.366  0.316 0.331 
F   43.739 44.388  46.437 44.427  54.837 56.746 
R
2
pre   0.779  0.790  0.725  0.690  0.794 0.715 
SEP   0.305 0.318  0.336 0.361  0.296 0.367 
OPN   7 6  7 6  7 6 
Contribution: 
Steric 0.435  0.115  0.434  0.110  0.456 0.110 
Electrostatic 0.501  0.337  0.502  0.335  0.481 0.341 
Hydrophobic   0.240    0.238   0.233 
HB acceptor    0.236    0.244   0.242 
MlogP 0.064  0.072  0.064  0.072  0.064 0.072 
Q
2, cross-validated correlation coefficient after the leave-one-out procedure; R
2
ncv,  
non-cross-validated correlation coefficient; SEE, standard error of estimate; F, ratio of R
2
ncv 
explained to unexplained = R
2
ncv/(1 − R
2
ncv); R
2
pre, predicted correlation coefficient for the test set of 
compounds; SEP, standard error of prediction; OPN, optimal number of principal components.  
Secondly, three alternate charges beside the Gasteiger-Huckel charge [21] (represented as (A) in 
Table 2), i.e., the (B) Gasteiger-Marsili charge [21], (C) Del-Re charge [22] and (D) Pullman 
charge [23], were applied to find the best charge assignments. Table 2 depicts the final results, where 
the Gasteiger-Huckel charge is demonstrated as obviously the optimal one.  
Thus based on the above results, further modeling was carried out using the substructure C and 
Gasteiger-Huckel charge calculated. Two alignment rules, i.e., the ligand- and receptor-based 
alignments were both employed to overlay the whole 109 compounds, resulting in two different 
aligned models. All subsequent CoMFA and CoMSIA models were then derived using the same 
training (82) and test (27 molecules) sets. To determine the reliability of these models, all crucial 
statistical parameters were analyzed here, including the Q
2 (leave-one-out), Q
2 (leave-group-out), non 
cross-validated correlation coefficient (R
2
ncv),  SEE, F-statistic values and predicted correlation 
coefficient (R
2
pre), R
2
boot (Bootstrap). 
For CoMFA analysis, steric, electrostatic and MlogP were fitted together in every possible form to 
build appropriate CoMFA models. Finally both the ligand- and receptor-based modeling using 
descriptors of steric, electrostatic fields and MlogP fields obtained proper reliability (Table 3) and got 
a result with Q
2 = 0.506, R
2
ncv = 0.838, SEE = 0.316, F = 54.837 with seven optimum components for 
ligand-based model, and Q
2 = 0.418, R
2
ncv = 0.856, SEE = 0.292, F = 114.875 with four optimum 
components for receptor-based model, respectively. When being tested by the independent test set, the 
ligand-based CoMFA model exhibited satisfactory predictive ability with R
2
pre = 0.794 and   
SEP = 0.296, but for the receptor-based model the statistical results (R
2
pre  = 0.481, SEP = 0.548) are 
not good enough. In both CoMFA models, electrostatic feature is found to make more contribution to 
the activity (~48% in ligand-based CoMFA and ~55% in receptor-based CoMFA). Int. J. Mol. Sci. 2011, 12               
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Table 2. Summary of CoMFA and CoMSIA results based on three different charges. 
PLS  
Statistics 
A B C D 
 CoMFA  CoMSIA  CoMFA  CoMSIA CoMFA CoMSIA CoMFA CoMSIA
Q
2   0.506 0.511  0.485 0.414 0.437 0.395 0.417 0.475 
R
2
ncv   0.838 0.819  0.772 0.695 0.783 0.833 0.827 0.930 
SEE  0.316 0.331  0.373 0.425 0.363 0.321 0.327 0.212 
F   54.837 56.746  42.301 43.834 45.149 52.739 50.525 94.645 
R
2
pre   0.794 0.715  0.712 0.554 0.735 0.539 0.791 0.465 
SEP   0.296 0.367  0.339 0.451 0.330 0.459 0.295 0.527 
OPN   7 6  6 4 6 7 7 10 
Contribution: 
Steric  0.456 0.110  0.450 0.106 0.445 0.100 0.449 0.112 
Electrostatic  0.481 0.341  0.485 0.351 0.493 0.312 0.493 0.335 
Hydrophobic   0.233   0.228   0.247   0.256 
HB acceptor   0.242   0.226   0.287   0.249 
MlogP  0.064 0.072  0.065 0.089 0.063 0.054 0.058 0.047 
Q
2, cross-validated correlation coefficient after the leave-one-out procedure; R
2
ncv,  
non-cross-validated correlation coefficient; SEE, standard error of estimate; F, ratio of R
2
ncv 
explained to unexplained = R
2
ncv/(1 − R
2
ncv); R
2
pre, predicted correlation coefficient for the test set of 
compounds; SEP, standard error of prediction; OPN, optimal number of principal components.  
For CoMSIA analysis, five field descriptors concerning with the steric, electrostatic, hydrophobic, 
HB donor and acceptor interactions were calculated using the same datasets as CoMFA analysis. 
Combined with MlogP, a total of these six parameters were fitted together in every possible form to 
build appropriate CoMSIA models. Finally the superior ligand- and receptor-based models were 
obtained with the highest Q
2 values using steric, electrostatic, hydrophobic, HB acceptor and MlogP 
parameters (Table 3). The ligand-based CoMSIA model has a Q
2 value of 0.511 with six optimum 
components, an R
2
ncv value of 0.819, a SEE value of 0.331 and an F value of 56.746. The   
docking-based CoMSIA model has a Q
2 value of 0.603 with three optimum components, an R
2
ncv value 
of 0.829, a SEE value of 0.316 and an F value of 125.886. Furthermore, both CoMSIA models indicate 
that electrostatic feature plays a major contribution to the antagonist activities. 
Normally, 3D-QSAR studies with a Q
2 greater than 0.5 are considered to be statistically 
significant [24]. In addition, higher R
2
ncv and F values as well as lower SEE values should also be 
considered as  the foundation of a reliable 3D-QSAR model. But the extensively accepted LOO   
cross-validated Q
2 is insufficient to assess the predictive power of the QSAR models [25]. Here we 
validate the models by predicting the activity (fpKi value) of the compounds in the test set using the 
above four models. For this purpose, the test set (27 molecules) which represents 32.9% of the training 
set, was used here to validate the accuracy of both the ligand- and receptor-based models.  Int. J. Mol. Sci. 2011, 12               
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Table 3. Summary of CoMFA and CoMSIA results. 
PLS Statistics 
Ligand-based Model  Receptor-based Model 
CoMFA CoMSIA  CoMFA  CoMSIA 
Q
2   0.506  0.511 0.418 0.603 
Q
2
cv(10)  0.493  0.343 0.388 0.599 
R
2
ncv   0.838  0.819 0.856 0.829 
R
2
boot  0.892  0.872 0.899 0.882 
SEE  0.316  0.331 0.292 0.316 
F   54.837 56.746  114.875 125.886 
R
2
pre    0.794  0.715 0.481 0.690 
SEP   0.296  0.367 0.548 0.406 
OPN   7  6 4 3 
Q
2
scrambling 
CSDEP  
−0.526 
0.972 
−0.498 
0.957 
0.471 
0.559 
0.521 
0.528 
dq
2/dr
2
yy  −0.145  0.046 1.048 0.678 
Contribution: 
Steric  0.456  0.110 0.433 0.121 
Electrostatic  0.481  0.341 0.546 0.383 
Hydrophobic    0.233  0.181 
HB  acceptor    0.242  0.294 
MlogP  0.064  0.072 0.022 0.022 
Q
2
cv(10), cross-validated correlation coefficient after the leave-group-out procedure (group 
number is 10); R
2
boot,  R
2 of boot strapping analysis (100 runs); Q
2
scrambling,  equals to 
(1 − (sSDEP)
2). Predictivity of the model using the scaled standard deviation of error of 
prediction (sSDEP) instead of the SDEP;  CSDEP, calculated cross-validated standard 
deviation of error of prediction; dq
2/dr
2
yy, slope of q
2 (calculated by SAMPLS using 
perturbed y-values, therefore denoted q
2) versus the correlation of the perturbed to the 
original  y-variables (denoted r
2
yy).  Q
2, cross-validated correlation coefficient after the 
leave-one-out procedure; R
2
ncv, non-cross-validated correlation coefficient; SEE, standard 
error of estimate; F, ratio of R
2
ncv explained to unexplained = R
2
ncv/(1 − R
2
ncv);  R
2
pre, 
predicted correlation coefficient for the test set of compounds; SEP, standard error of 
prediction; OPN, optimal number of principal components. 
Before the final validation by the test set, an initial inspection of the fitted/predicted activities 
revealed poor prediction for several inhibitors which were considered as outliers in this work. For the 
ligand-based models, outliers are compounds 24, 29, 34, 81, 88 and 104; for the receptor-based ones, 
outliers are 6, 24, 34, 68, 81, 88 and 97. Several reasons, like unmatched structure, different active 
conformation or more specific molecular mechanisms, may result in the existence of outliers. A 
particular careful examination of the outliers may provide additional information determining their 
peculiarities; therefore, in this study all outliers were attentively checked and finally divided into 
three groups.  
(1) Compound 24 has a special substructure of aromatic ring-A which is different from any other 
chemicals in the data set, and ring-A in our further analysis has been identified as very important in 
affecting the activity; Molecule 81 is the only antagonist in the dataset with a type b R3 substituent Int. J. Mol. Sci. 2011, 12               
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( N
O
) in skeleton type H group of compounds 76–100. This unique molecular structure may cause the 
larger standard deviations from the mean of the residuals for the two compounds.  
(2) In structure, compound 34 belongs to type E skeleton which includes 33–39, a total of seven  
BAZ-based derivatives with antagonist activity ranging from 6.6 to 8.1. Though having no unique 
substructure, compared with others in this group, 34 exhibited an extremely lower (also the lowest in 
the dataset) fpKi value of 5.6. The case of molecule 29 is similar to 34. Throughout the whole dataset, 
it is easy to observe that when falling into same skeleton type and possessing same R1, R2 substituents, 
all molecules with type a R3 substituent ( N ) are always more active than those with b type of R3 
group. However, 29 is an exception, exhibiting lower biological activity than corresponding molecule 
30. Whether this disagreement in variance of the structure-activity is due to different binding 
conformation or specific interaction mechanism still needs further experiments to determine. 
(3) As to compounds 6, 68, 88, 97 and 104, they all have a higher residual between the 
experimental and predicted activity (fpKi residual is larger than 0.7–0.9) and thus are treated as 
outliers. This discrepancy, we speculate, on the one hand indicates that these particular BAZ 
derivatives may not be typical of the rest of the data, and on the other hand, suggests the necessity to 
recruit more plenteous and accurate experimental data with more diversified molecular structures.  
After elimination of these outliers, both the CoMFA and CoMSIA models obtained from the   
ligand-based alignment exhibit good prediction (Q
2 is larger than 0.5 and R
2
pre is larger than 0.71) 
(Table 3), indicating the ligand-based alignment rule is good. For receptor-based alignment, CoMSIA 
model exhibits good prediction (Q
2 is 0.603 and R
2
pre is 0.690), but CoMFA model (Q
2 is 0.418 and 
R
2
pre is only 0.481) is not good enough.  
In addition, besides the external test set, another important procedure, i.e., the progressive 
scrambling was also used to validate the predictive ability of the models with the same principal 
component numbers as adopted in Table 3, which gauges the dependence of the model on chance 
correlations [26]. As seen from Table 3, in almost all cases the Q
2
scrambling values are slightly lower than 
the Q
2 values. This is reasonable because Q
2
scrambling values are known to be more conservative than 
those of LOO/CV PLS Q
2 ones [27]. And the calculated cross-validated standard deviations of error of 
prediction (CSDEP) are slightly larger than the SEP values. By this comparison, receptor-based 
models show their superiority to the ligand-based ones, due to the former’s much more reasonable 
Q
2
scrambling values for CoMFA and CoMSIA models than the latter’s. Thus, subsequently the optimal 
model in this study, i.e., the CoMSIA receptor-based model, was utilized for further assessment   
and discussion.  
The observed and CoMSIA predicted DA D3 receptor inhibitory activities for both receptor-based 
and ligand-based models are shown in Table S5. Figure 3 depicts the actual versus predicted fpKi 
values plot for both the training (filled black square) and test (filled blue diamond) set molecules of the 
whole dataset based on receptor-based CoMSIA model. As observed, all the points are rather 
uniformly distributed around the regression line in this figure and the predicted activities are almost as 
accurate as the experimental data, indicating a proper correlation between the predicted and 
experimental activities of the dataset and the reliability of the obtained models.  Int. J. Mol. Sci. 2011, 12               
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2.2. MlogP Contribution  
Hydrophobicity is one of the most crucial properties related to biomolecular interactions, which can 
be interpreted in terms of the association of non–polar groups or molecules in an aqueous environment 
which arises from the tendency of water to exclude non–polar molecules [28]. To quantitatively depict 
the hydrophobicity of a molecule, various molecular descriptors are used, in which lipophilicity 
represented by logP is  most common [29]. Traditionally, this descriptor depicts the lipophilicity of a 
molecule, which is the logarithm of the partition coefficient of the molecule in a lipidic phase and an 
aqueous phase. It represents the tendency of the compound to prefer a lipidic environment to an 
aqueous one. In our present work, MlogP, a calculated logP parameter was calculated by Dragon 5.4 
software [30]. The principle of MlogP calculation was invented by Moriguchi et al. who carried out a 
multiple regression analysis of a set of 1230 organic molecules including general aliphatic, aromatic, 
and heterocyclic compounds, together with complex drugs and agrochemicals when deriving their 
‘simple method’ of calculating logP [31]. The larger MlogP value a molecule possesses, the higher 
lipophilicity and larger hydrophobicity it has. Whereas, hydrophobic field in CoMSIA is another 
hydrophobic index, describing the specific distribution of the hydrophobic property in 3D-space or 
surface area of a molecule [32]. In CoMSIA methods, steric, electrostatic, HB donor and acceptor 
interactions are all determined using a probe atom with a charge of +1, 0 or –1, and the corresponding 
field points are then placed at the extrema of the interactions [33]. But for the hydrophobic field, the 
field points are positioned at the centre of hydrophobic groups such as phenyl, halogens and alkyl, and 
then these field points are used to describe molecules and compare their similarity [33]. Presently, a 
correlation regression analysis was carried out to MlogP and the hydrophobic field indices in CoMSIA, 
and the result showed that they were totally independent of each other.  
Figure 3. The receptor-based correlation plots of the predicted versus the actual fpKi 
values using the training set (filled black square) and the test set (filled blue diamond) 
based on CoMSIA model. 
 
To exploit the impact of hydrophobicity of the molecules on their biological activity (fpKi here), 
MlogP is used as a descriptor in our PLS analysis in both the CoMFA and CoMSIA analyses. But Int. J. Mol. Sci. 2011, 12               
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before this, 3D-QSAR analyses were first performed without MlogP parameter employed using the 
same training/test set and molecular alignment rule, and Table 4 shows the optimal results. Obviously, 
it can be seen from the table that without MlogP descriptor, all models’ Q
2 and R
2
pre values are much 
lower and no CoMFA or CoMSIA models with satisfactory statistical results could be obtained, further 
demonstrating the crucial role MlogP parameter plays in building appropriate 3D-QSAR models. This 
conclusion is confirmed by the study of Corwin Hansch and his colleagues, in which they studied the 
role of hydrophobicity (the main parameter is ClogP) of 22 individual series of antagonists (every 
series of antagonists has less than 21 compounds) binding to DA receptors, and finally found that the 
hydrophobic term is the most important factor in the DA interactions [19]. 
Table 4. Statistical results of CoMFA and CoMSIA models without MlogP used. 
PLS Statistics 
Ligand-based Model  Receptor-based Model 
CoMFA CoMSIA CoMFA CoMSIA 
Q
2   0.351 0.443 0.366 0.576 
R
2
ncv   0.792 0.838 0.923 0.892 
SEE  0.356 0.314 0.213 0.251 
F   47.659 64.772  231.880  215.375 
R
2
pre    0.668 0.471 0.416 0.604 
SEP   0.384 0.537 0.606 0.475 
OPN   6 6 4 3 
Contribution: 
Steric  0.510 0.122 0.486 0.140 
Electrostatic  0.490 0.318 0.514 0.367 
Hydrophobic   0.288  0.205 
HB  acceptor   0.272  0.287 
Q
2, cross-validated correlation coefficient after the leave-one-out procedure; R
2
ncv,  
non-cross-validated correlation coefficient; SEE, standard error of estimate; F, ratio of R
2
ncv 
explained to unexplained = R
2
ncv/(1 − R
2
ncv); R
2
pre, predicted correlation coefficient for the test set of 
compounds; SEP, standard error of prediction; OPN, optimal number of principal components. 
2.3. 3D-QSAR Contour Maps 
In our study, various stdev*coeff contour maps were constructed to view important features for the 
interaction between ligand and the target protein, based on the receptor-based optimal CoMSIA 
models. These contour maps allow identification of those positions that require a particular 
physicochemical property to enhance the bioactivity of a ligand [34] and, therefore, have been widely 
used in recent 3D-QSAR studies [15]. In our present work, the maps generated depicted regions with 
scaled coefficients: 85% (favored) or 15% (disfavored). As compound 9 (Figure 4) is one of the most 
active molecules in the whole dataset (fpKi value is 9.1), in all the following contour maps (Figure 5) 
it is shown as an example molecule to exploit the possible interactions between the benzazepine 
antagonists and dopamine D3 receptor. Int. J. Mol. Sci. 2011, 12               
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Figure 4. The structure of compound 9 [11]. R1, R2 and R3 substituents are –CF2CH3, H 
and  N
O
, respectively.  
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2.4. CoMSIA Contour Maps Analysis 
The contributions of the steric fields for the optimal CoMSIA model were graphically displayed in 
contour maps in Figure 5A, where the steric field defined by the green colored contours represents 
regions of favorable steric effect, while yellow colored contours represent regions of unfavorable steric 
effect, respectively. It can be easily found that a large positive steric (green) region appears above  
ring-A and ring-B, especially around the R1  substituent (position-2 in ring-A). Thus, molecules 
carrying a bulky ring or substituent at position-2 in ring-A should be more active than those with a 
smaller substituent, or without a substituent, like that molecules 18 (fpKi = 8.4) and 19 (fpKi = 7.6) 
with a bulky substituent such as -pir are more active than molecules 3 (fpKi = 7.2) and 4 (fpKi = 7.0) 
with a –CH3 in this position. To improve the inhibition potency of the set of compounds we therefore 
need to try to develop new analogs with increasing steric substituents in these regions. In contrast, two 
negative steric (yellow) regions appear mainly above the plane of ring-C, the position-15 and ring-D, 
drawing a conclusion that a substituent of bulk steric at this position disbenifits the biological activity 
of the molecules, which is illustrated by the fact that compounds 95 (fpKi = 6.6) and 96 (fpKi = 6.9) 
with a –CH3 in position-15 exhibit lower activities than molecules 78 (fpKi = 7.4), 79 (fpKi = 7.5),  
85 (fpKi = 8.2) and 86 (fpKi = 7.6) which have no substituent in that position at all.  
Electrostatic fields based on the PLS analysis of the CoMSIA models are shown in Figure 5B. A 
small red isopleth around the R3 substituent in ring-D indicates the area’s preference for negative 
charged substituents. For compounds 8 (fpKi  =  8.8) and 11 (fpKi  =  9.1), due to the strong 
electronegativity of nitrogen and oxygen atoms in R3 substituent, their activities are greater than 
compounds 7 (fpKi  =  8.4) and 10 (fpKi  =  9.0). A blue region appears below the plane of ring-D 
suggesting the preference for positive charges at this region.  
The CoMSIA hydrophobic contour maps of affinity for DA D3 receptor are depicted in Figure 5C, 
where yellow and white contours highlight areas where hydrophobic and hydrophilic properties are 
preferred. Two yellow isopleths, above the R1 substituent in ring-A (position-2) and around the plane 
of ring-C and position-15,  indicate that hydrophobic groups (like –OMe, –OEt, –F, –Cl, –Br) are 
beneficial here to enhance the activity. This is illustrated by the example of compound 15 with   
–CF2CH3 at this position showing a much higher activity than any other compound in the   Int. J. Mol. Sci. 2011, 12               
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group of 1–19. Another yellow isopleth appears above the R3 substituent in ring-D indicating that 
hydrophobic groups in these positions are beneficial to enhance the activity. White polyhedra appear 
near ring-D, indicating that hydrophilic (like hydroxy or amido) groups here are correlated with good 
antagonist activity of the molecules. 
Figure 5D depicts the HB acceptor contour maps of the CoMSIA models. Magenta contours 
encompass regions where a hydrogen bond acceptor will lead to improved biological activity, while a 
HB acceptor located near the cyan regions will result in impaired biological activity. From this figure, 
a large magenta contour is observed surrounding R1 substituent and ring-A, supporting the requirement 
of HB acceptor in the location to improve the activity. Compounds 7–16 which exhibit much higher 
activity than any others in the dataset are just such cases, due to their R1 substituent with F atom. 
Another large magenta contour surrounding the R3 substituent and ring-D indicates that HB acceptor is 
beneficial to the activity, which further illustrates why this new kind of DA D3 receptor antagonist 
with Part 4 basic structure (ring-D has three nitrogen atoms which seems to be a powerful HB receptor) 
may express higher activity.  
Figure 5. CoMSIA StDev*Coeff contour plots. (A) Steric (green/yellow) contour map in 
combination with compound 9. Green contours indicate regions where bulky groups 
increase activity; yellow contours indicate regions where bulky groups decrease activity; 
(B) Electrostatic contour map (red/blue) in combination with compound 9. Red contours 
indicate regions where negative charges increase activity; blue contours indicate regions 
where positive charges increase activity; (C) Hydrophobic contour map (yellow/white) in 
combination with compound 9. Yellow contours indicate regions where hydrophobic 
substituents enhance activity; white contours indicate regions where hydrophilic 
substituents enhance activity; (D) HB acceptor contour map (magenta/red) in combination 
with compound 9. Magenta contours indicate regions where HB receptors on the receptor 
promote the affinity; cyan contours indicate regions where HB acceptors on the receptor 
demote the affinity.  
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Recently, using the dopamine D3 receptor antagonist SB277011 as a starting point, and from 
examination of molecular models, two derivatives named by m1 and m2 (Figure 6) were synthesized 
and evaluated by Austin and his colleagues, which exhibited nanomolar affinities for D3 receptors 
(Ki = 4.0 nM for m1 and Ki = 5.0 nM for m2, respectively) [35,36]. Integration of a triazole moiety 
into the N-alkyl spacer yielded selective D3 ligands as exemplified for m3, which also showed a 
greater D3 affinity of 4.3 nM [1]. In comparing m1~3 with SB277011 it is apparent that the substituent 
in arylcarbamide moiety may play an important role in improving the activity, and the variations of the 
ring size in ring-B exert an influence on the activity. Moreover, introduction of a   
trans-1,4-cyclohexylethyl spacer, as well as further optimizations of the arylcarbamide moiety and the 
position of attachment for the cyano- or methylsulfonyl-function, has yielded potent and selective D3 
antagonists [1]. All the above conclusions confirm part of our results that ring-A plays a very 
important role in design of DA D3 antagonist with high activity. As to their conclusions that 
introduction of a trans-1,4-cyclohexylethyl spacer, position of attachment for the cyano- or 
methylsulfonyl-function will yield more potent and selective D3 antagonists, since the structures of the 
molecules they studied are quite different from our dataset both in skeleton and the substructures, we 
cannot draw a similar conclusion unless more data enclosing such specific compounds under the same 
experimental environment are supplemented into our models. 
Figure 6. The structures of SB277011A, m1, m2 and m3 [1]. 
 
2.5. Homology Modeling Results 
Figure 7 shows the structural superposition of the DA D3 receptor homology model to the X-ray 
crystal structure of template 1F88_A which was created by SuperPose web server 1.0 [37]. Seemingly, 
the sequence identity between DA D3 receptor  homology model and the template 1F88_A is 
somewhat low, only 21.4%, with a similarity of 35.6%. However, after a careful analysis of the 
alignment of the model and template, the sequence identity in the important seven transmembrane 
(TM) domains which are regarded as the structurally conserved regions is found to be 33.1% with a 
similarity of 54.4%, satisfying the normal criterion that a sequence identity higher than 30% could be 
used to predict the protein structure [38]. Finally, we assessed the geometric qualities of the model 
using PROCHECK and the results showed that: for ramachandran plot: 86.6% core, 10.0% allow, 
3.4% gener and 0.0% disall; for main-chain and side-chain params: 11 better, 0 inside and 0 worse. 
And as seen in Figure 7B, the template protein 1F88 chain A (green ribbon) are well superposed with Int. J. Mol. Sci. 2011, 12               
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the DA D3 receptor model structure (red ribbon) from homology modeling. All these results provided 
a good validation of the modeled structure of D3 dopamine receptor. 
Figure 7A shows the important positions for the folding of the helices that were aligned. The length 
of the loop regions between the DA D3 receptor loop sequences and the template 1F88_A is 
comparable, except loop IL3 (the region between TM5 and TM6). This is because the DA D3 receptor 
IL3 loop (with 104 residues) is much longer than that of bovine rhodopsin (with only 12 residues) [39]. 
Here the N-terminus and the intracellular loop IL3 were omitted due to the fact that they are 
presumably remote from the binding site, and furthermore, were not found to be crucial for ligand 
binding in previous studies on chimeric receptors [39,40]. Varady et al. recently also demonstrated that 
omission of even more loops still allows for construction and simulation of a meaningful D3 model, 
which was used successfully by the authors for structure-based virtual screening [41]. Considering all 
these features, the homology model we built was found to be in good agreement with previous 
models [39,40]. In addition, many key amino acids (such as CYS101, ILE105, LEU106, VAL151, 
PHE175, PHE184, PRO254 and ALA251) interacting with the DA D3 receptor antagonists in the 
binding site, are well overlaid in 3D space in both structures.  
Figure 7. Homology modeling results. (A) Sequence alignment of bovine rhodopsin (1F88 
chain A) and the DA D3 receptor homology model. The identical residues are shaded in 
blue, while similar residues are shaded in green. The seven TM domains (named TM1~7) 
are boxed by a red border; (B) Superposition of template protein 1F88 chain A (green 
ribbon) and the DA D3 receptor model structure (red ribbon) from homology modeling. 
Blue and pink dot regions are the binding pocket of compound 9 and the template protein 
1F88 chain A, respectively. 
 
2.6. Docking Results 
In order to explore the real binding environment where the ligand interacts within the protein, 
docking studies were carried out on these compounds. Figure 7B shows the binding pocket we 
generated (blue dot region). It is observed that this binding pocket is partly overlapped with the Int. J. Mol. Sci. 2011, 12               
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binding pocket in the template protein 1F88 chain A. Furthermore, the binding site we generated in the 
seven TM domains corresponds well to the studies of Frank Boeckler et al. [1,39]. All these findings 
suggest that the binding site we found is appropriate for the study of DA D3 receptor antagonists. 
Presently, all 109 compounds were docked into the possible active site, and finally each compound got 
20 possible active conformations with different total scores. The selection was made in such a way that 
docking conformations with comparatively higher scores were chosen for those compounds with 
higher antagonist activities, and vice versa. Finally, a correlation analysis between the docking scores 
and the fpKi values of the whole dataset was carried out, resulting in a R
2 of 0.39 and a highest 
docking score of 4.4 for the antagonists. This result not only proves the reasonability of the docking, as 
well as the homology protein model, but also reveals a proper correlationship between the docking 
conformation and the antagonist potency of the fused benzazepine derivatives.  
2.7. Molecular Dynamics Simulations 
In the present work, we performed 4 ns molecular dynamics simulations of DA D3 receptors with 
ligand 9 based on the docked complex structure to obtain a dynamical picture of the conformational 
changes. The main purpose of the simulations is to study the conformational alterations of ligand 9 in 
the DA D3 binding pocket. The RMSDs of the trajectory with respect to their initial structure ranging 
from 2.1 to 2.7 Ǻ are depicted in Figure 8A. After 2.5 ns, the RMSD of the complex reached about  
2.2  Ǻ and almost retained this value for the entire simulation. This clearly indicates metastable 
conformation after 2.5 ns of simulation for docked complex structure. A superposition of the average 
structure of ensemble for the last 1 ns and the docked structure is shown in Figure 8B, where the pink 
ribbon represents initial structure for the docked complex, the green ribbon represents the   
MD-simulated structure, respectively. And compound 9 is represented in pink for initial complex and 
green for the final average complex, respectively.  
In Figure 8B it can be observed that the docked complex and MD average structure are in the same 
binding site. There is no significant difference between the average structure and the docked complex. 
Ring-A, -B and -C are superimposed well in these two models. This indicates the reasonability of the 
homology model and the docking results. The only difference is that ring-D and R3 substituent in MD 
average structure is in front of the docked complex. In Figure 7A, the sequence similarity between 
TM5 and TM6 (IL3 part) is not very high. After the optimization in MD simulations this part becomes 
more reasonable and the space between TM5 and TM6 becomes smaller. In order to bind into this 
pocket, the ring-D and R3 substituent of compound 9 must bend to the TM5.  
As the most potent antagonist in the dataset, compound 9 is chosen as an illustration to analyze the 
MD results. Figure 9A shows the binding pocket in the protein. Figure 9B shows the steric amino acid 
residues around the compound in the binding pocket. It can easily be seen that no steric amino acid 
residues appear above ring-A, especially around the R1 substituent (position-2 in ring-A). However, 
several crucial amino acid residues are observed around some specific positions of the molecules. For 
example, PHE175, SER180, PHE184, PHE188 and PRO254 lie above ring-C, position-15 and ring-D. 
These results further confirm the results of the CoMSIA model (Figure 5A), where bulky substituents 
in position-2 (ring-A) improve the activity, but bulky groups at positions-11, -15 (ring-C) and ring-D 
impair the activity. Int. J. Mol. Sci. 2011, 12               
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Figure 8. MD simulations results. (A) Plot of the RMSD of docked complex versus the 
MD simulation time in the MD-simulated structures; (B) View of superimposed backbone 
atoms of the average structure of the last 1000 ps of the MD simulation (green) and the 
initial structure (pink) for compound 9 and DA D3 receptor complex. Compound 9 is 
represented in pink for initial complex and green for the final average complex. Different 
colors represent different kinds of atoms: For compound 9, common C is shown in pink 
and for amino acid residues common C is shown in cyan, white for H, blue for N, red for 
O, cyan-blue for F and yellow for S, respectively. 
 
In Figure 9C, hydrophobic amino acid residues CYS101, ILE105, LEU106 and VAL151 appear 
above the R1 substituent in ring-A (position-2), and ALA250, LEU251 appear above the R3 substituent 
in ring-D, indicating that compounds with hydrophobic groups in these positions may have higher 
activity. Hydrophilic amino acid residues SER180 and PRO254 above ring-D suggest that compounds 
with hydrophobic groups in these regions may reduce the activity. These MD results correspond well 
to our previous CoMSIA analysis, where in Figure 5C (the hydrophobic field contour map), one 
yellow isopleth above the R1 substituent and ring-A (position-2) indicates the favor of the locations for 
hydrophobic groups, and white polyhedra appear above ring-D which implies a preference for 
hydrophilic groups in the areas.  
These conclusions are well consistent with the findings obtained from the CoMSIA contour maps 
analysis, in that bulky R1 substituent in ring-A of antagonist can be able to interact with receptor 
simply due to the fact that it may well fit in the binding pocket. In addition R1 substituent and R3 
substituent of antagonists with hydrophobic group are favorable to enhance the activity.  Int. J. Mol. Sci. 2011, 12               
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Figure 9. The binding pocket formed around molecule 9. (A) Superposition of the MD 
simulation (green) and the initial structure (pink) for DA D3 receptor. Blue dot regions are 
the binding pocket of compound 9; (B) Steric amino acid residues around the compound in 
the active docking pocket; (C) Positions of hydrophobic (pink border) and hydrophilic 
(blue border) amino acid residues. 
 
3. Materials and Methods 
3.1. Compounds and Activity 
After discarding six compounds with unspecified inhibitory activities, a total of 110 tricyclic 
derivatives synthesized as the DA D3 receptor antagonists [7,11] were used as dataset in the present 
work, with their fpKi values (functional pKi obtained from the GTPγS functional assay) employed as 
the biological activity (Tables S1–S4, supplementary materials). Although all compounds in this 
dataset are also DA D2 antagonists, most of their fpKi values for DA D2 receptor are undefined due to 
experimental difficulty in the literatures, thus here we only study their D3 receptor antagonist 
properties. In structure, 110 tricyclic derivatives were divided into skeleton types A–K, where   
types A–D contain 26 compounds (Table S1), E~J 72 compounds (Table S2) and K with only 4 
molecules (Table S3) whose structures are independent of any other types in the whole dataset. In this 
work, only molecule 1 was omitted as it has no common substructure with others used. In a ratio of 
about 3:1, the remaining dataset, composed of 109 BAZ compounds, were divided into a training set 
(82 molecules) to build the subsequent QSAR model and a test set (27 molecules) for validating the 
predictability of the model. The compounds in the test set were chosen to make sure that their fpKi 
values are uniformly distributed in the whole biological activity range of the dataset. The fpKi values 
are considered as dependent variables in the CoMFA and CoMSIA analyses. Energy minimization was Int. J. Mol. Sci. 2011, 12               
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performed using SYBYL 6.9 package (Tripos Associates, St. Louis, MO, U.S.), tripos force field was 
used and conjugate gradient method with convergence criterion was set as 0.05 kcal/mol for this 
process. Partial atomic charges were calculated by the Gasteiger-Huckel method [21].  
3.2. Homology Modeling 
The accurate 3D structure of DA receptors is still unavailable [42], thus homology modeling, based 
on consensus alignment [43], was used here to build the D3 receptor structure. Homology modeling is 
an effective method for predicting a three dimensional structure, provided that homologous proteins 
exist whose 3D structures are known. In this work, the rhodopsin X-ray structure (PDB entry: 1F88, 
chain A, 2.8 Å) has been applied since it belongs to the same subfamily of the GPCRs with dopamine 
receptors [40,44]. The target DA D3 receptor which has 400 amino acids (Swiss-Prot Accession 
Number: P35462.2) was taken from the NCBI website (http://www.ncbi.nlm.nih.gov). 
The template has about 32% sequence similarity with DA receptors for the whole sequence and 
about 55% for the structurally conserved regions, i.e., the active center [39]. The modeling process 
was carried out by ESyPred3D web server 1.0 [45], which mainly used the MODELLER package [45], 
and also performed sequence alignment by combining, weighting and screening the results of several 
multiple alignment programs. Finally, the generated D3 dopamine receptor model was validated by 
PROCHECK program (http://nihserver.mbi.ucla.edu/SAVS/) [46]. The aim of PROCHECK is to 
assess how normal, or conversely, how unusual the geometry of the residues in a given protein 
structure is, as compared with stereo chemical parameters derived from well refined and high 
resolution structures [42]. All H-atoms were subsequently added to the unoccupied valence of heavy 
atoms at the corresponding neutral state using the biopolymer module of SYBYL 6.9 package. 
3.3. Molecular Docking 
To determine the probable binding conformations and offer more insight into understanding the 
interactions between DA D3 receptor and its antagonist, molecular docking analysis was carried out 
using the Surflex docking of SYBYL package. This docking approach aligns the ligand to a 
“protomol” or idealized ligand in the active site of the target. Our molecular docking executes the 
following steps: Firstly, the protein structure obtained from homology modeling was imported into 
Surflex and then hydrogens are added. Secondly, the protomol was generated using a ligand-based 
approach. During the protomol generating process, the specification of two parameters is critical for 
forming appropriate binding pocket. One is the protomol_bloat determining how far the site should 
extend from a potential ligand, and the other is the protomol_threshold determining how deep into the 
protein the atomic probes used to define the protomol can penetrate.The protomol_bloat value was set 
at 0 and the protomol_threshold value at 0.49 when a reasonable binding pocket was obtained. Finally, 
all the antagonists were docked into the binding pocket and each of them got 20 possible active 
docking conformations with different scores. During the docking process, the protein was considered 
as rigid and the antagonist molecules flexible, with all other parameters adopted default values.  Int. J. Mol. Sci. 2011, 12               
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3.4. Conformational Sampling and Alignment 
Based on an atom-by-atom superimposition principle, the alignment of the molecules was carried 
out by the ALIGN DATABASE command in SYBYL. In the present study, ligand-based alignment 
and receptor-based alignment rules were adopted. In the ligand-based alignment, molecule 9 with the 
highest fpKi values (fpKi = 9.1) was chosen as the template molecule. Figure 10A shows the common 
substructure depicted in red, and Figure 10B shows the resulting ligand-based alignment model.  
The other alignment we used is the receptor-based alignment. After docking process, the 
conformations for all compounds with optimal scores in DA D3 receptor protein could not present a 
statistically significant result. Therefore, the optimal conformation of each molecule was selected from 
the 20 conformations in order to ensure the score and the activity have a good correlation. Finally we 
got a correlation coefficient R
2 of 0.39. Then all molecules’ partial atomic charges were calculated by 
the Gasteiger-Huckel method [21]. The receptor-based alignment model is shown in Figure 10C. 
Figure 10. Molecular alignment of compounds in the whole dataset. (A) Common 
substructure of the molecules is shown in red based on template compound 9;   
(B) Ligand-based alignment of all the compounds; (C) Receptor-based alignment of all 
the compounds.  
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3.5. Descriptor Calculation 
CoMFA [47] and CoMSIA [48] were performed to build the models in order to reveal the 
relationship between 3D structural features and activities by employing the standard option of 
SYBYL. In CoMFA analysis, the superimposed molecules are kept in a 3D grid and steric and 
electrostatic fields are then calculated at various grid points using Lennard-Jonnes and Coulombic 
potentials, respectively [24]. CoMFA method only calculates steric and electrostatic interactions, yet 
CoMSIA also calculates hydrophobic, hydrogen-bond (HB) donor and HB acceptor interactions. The 
basic assumption of CoMSIA is that a suitable sampling of the steric, electrostatic, hydrophobic and 
HB acceptor interactions generated around a set of aligned molecules with a probe atom might provide 
all important features for understanding their biological activities, and that the changes in binding 
affinities of ligands are related to changes in molecular properties [49]. 
In our present work, the CoMFA and CoMSIA models were generated by SYBYL with default 
parameters. To derive the CoMFA and CoMSIA descriptor fields, a 3D cubic lattice with grid spacing 
of 2Å in x, y, and z directions, was generated automatically to encompass the aligned molecules. All 
CoMFA calculations were accomplished using a sp
3 carbon atom with a charge of +1.00, a cut off 
value of 30 kcal/mol for the Lennard-Jones and Coulomb-type potential, and a constant dielectric 
function. The probe atom was placed at each lattice point, and their steric and electrostatic interactions 
with each atom in the molecule were computed using the CoMFA standard scaling. CoMSIA 
similarity indices descriptors were also derived within a lattice box with a grid spacing of 2 Å and a 
sp
3 carbon with +1 charge as probe atom. A Gaussian function was used to evaluate the mutual 
distance between the probe atom and each molecule atom. CoMSIA similarity indices (AF) for a 
molecule j with atom i at a grid point q are calculated by Equation 1 as follows: 

2
,
q
,
iq r
ik k probe k F e j A
  
           (1) 
where  ωprobe,k is the probe atom with radius 1 Å, charge +1, hydrophobicity +1, hydrogen bond 
donating +1 and hydrogen bond accepting +1. ωik is the actual value of the physicochemical property k 
of atom i. riq is the mutual distance between the probe atom at grid point q and item i of the test 
molecule [50].  
In addition, in order to deeply explore the impact of hydrophobic property of the molecules on their 
DA D3 antagonist potency, another hydrophobic parameter besides the hydrophobic field in 
CoMSIA analysis, i.e., MlogP [31], was also calculated by Dragon professional version 5.4 [30], and 
used in the building of 3D QSAR models. Dragon is an application software for calculation of 
1664  various molecular descriptors for each molecule. These descriptors can be used to  evaluate 
molecular structure–activity or structure–property relationships, as well as for similarity analysis and 
high-throughput screening of molecule databases (Dragon user’s manual 
(http://www.talete.mi.it/help/dragon_help/index.html).  
3.6. Calculation and Validation of 3D-QSAR Models 
To obtain statistically significant 3D-QSAR models, the Partial Least Squares (PLS) regression was 
used to analyze the dataset by correlating the variation in their fpKi values (the dependent variable) Int. J. Mol. Sci. 2011, 12               
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with variations in their CoMFA/CoMSIA interaction fields (the independent variables). The advantage 
of this method is that it can reduce large numbers of original descriptors to a few principal components 
(PCs) that are linear combinations of the original descriptors [51]. The optimum number of PCs was 
determined by the leave-one-out (LOO) cross-validation procedure. Then with this optimal PC 
number, a non-cross-validation analysis was carried out, and the Pearson coefficient (R
2
ncv) and 
standard error of estimates (SEE) were calculated [51]. 
During PLS process, to evaluate the reliability of the model generated, several statistical parameters 
including the Q
2 and above R
2
ncv are crucial. As a cross-validated coefficient, Q
2 is used as a statistical 
index of the predictive power of the model, and is calculated by Equation 2 where the Ypredicted, Yobserved 
and Ymean are predicted actual and mean values of the target property, respectively [49]. 
2
2
2
()
1
()
predicted observed
Y
observed mean
Y
YY
q
YY





       (2) 
When assessing the predictive power of the QSAR model derived using the training set, an 
independent test set was used and their biological activities were predicted. The predictive R
2 (R
2 pre) 
value is calculated using Equation 3.  
2
pre= (SS PRESS)/SS R         (3) 
where SS is the sum of squared deviations between the biological activity of the test set and the mean 
activity of training set molecules, and PRESS is the sum of squared deviations between the actual and 
the predicted activities of the test set molecules [52]. Finally, the CoMFA/CoMSIA results were 
graphically represented by field contour maps, where the coefficients were generated using the field 
type ‘‘Stdev*Coeff’’. 
3.7. Molecular Dynamics Simulations 
Molecular dynamics simulations were carried out using Amber 10 [53] by starting with the docked 
structure of compound 9. Based on the general atom force field (GAFF) [54] and the AM1-BCC 
charge scheme [55] ligand parameters and charges were determined. The protein parameters were 
described by standard AMBER force field for bioorganic systems (ff03) [56]. The system neutralized 
with 10 counter chloridion ions, was solvated in a rectangular box of TIP3P water, keeping a minimum 
distance of 12 Å between the solute and each face of the box (92.33  ×  82.63  ×  86.55). The total 
number of the atoms of the simulation system was 53327 including the complex and waters. A cutoff 
distance of 10 angstrom was used to compute the nonbonded interactions, and periodic boundary 
conditions were applied. To remove possible bad contacts, the complex was minimized by a multistep 
procedure including 2000 steepest-descent steps followed by 2000 conjugate-gradient steps. Constant 
volume dynamics with a cutoff of 10Å was chosen. SHAKE was turned on for bonds involving 
hydrogen atoms [57]. 
Firstly, the minimized systems were gradually heated to 300 K at a constant force  of  
2.0 kcal mol
−1 Ǻ
−2. This was followed by a 50 ps pressure-constant period to raise the density while 
still constraining the complex atoms. After that, a 500 ps Langevin dynamics calculation with a 
collision frequency of 1 ps
−1 was performed with a 2 fs time step in the NPT ensemble, at a constant Int. J. Mol. Sci. 2011, 12               
 
 
1217
temperature of 300 K. Finally, the production phase was taken 4 ns, with a 2 fs time step. Using 
default values, the long-range electrostatics was treated by the particle-mesh-Ewald method [58].  
4. Conclusions  
A 3D-QSAR study using CoMFA and CoMSIA methods was carried out for the first time on a 
series of 110 BAZ-based DA D3 receptor antagonists. Based on reasonable Q
2, R
2
ncv, and Rpre
2 values, 
the obtained optimal models exhibited proper predictability. A good consistency was also found 
between our MD results and the 3D-QSAR models. By analysis of both the models and the derived 
contour maps, significant regions influencing the potency of dopamine D3 receptor antagonists were 
identified: (1) Ring-A, position-2 and R3 substituent in ring-D are key regions to the activity of the 
antagonists; (2) Molecules with large negative charge in R3 substituent or a bulky steric substituent at 
position-2 will lead to improved activity; (3) Hydrophobicity of the molecule represented by MlogP 
was found to be essential for building satisfactory QSAR models. And hydrophobic groups in both R1 
substituent of ring-A and regions around ring-C plane and position-15 are especially sensitive areas for 
improving the binding affinity of the molecules. All these results can hopefully provide information 
for better understanding the interaction of D3 receptor-antagonists and help in the design of new DA 
D3 antagonists in the future. 
Acknowledgements 
The authors are grateful to the support of the Doctoral Fund (1000_893361) and Youth Teacher 
Fund (1000_893231) of Dalian University of Technology. 
References 
1.  Boeckler, F.; Gmeiner, P. The structural evolution of dopamine d3 receptor ligands:   
Structure-activity relationships and selected neuropharmacological aspects. Pharmacol. Ther. 
2006, 112, 281-333. 
2.  Sokoloff, P.; Giros, B.; Martres, M.P.; Bouthenet, M.L.; Schwartz, J.C. Molecular cloning and 
characterization of a novel dopamine receptor (d3) as a target for neuroleptics. Nature. 1990, 347, 
146-151. 
3.  Levesque, D. Aminotetralin drugs and d3 receptor functions. What may partially selective d3 
receptor ligands tell us about dopamine d3 receptor functions? Biochem. Pharmacol. 1996, 52, 
511-518. 
4.  Salama, I.; Schlotter, K.; Utz, W.; Hübner, H.; Gmeiner, P.; Boeckler, F. Comfa and comsia 
investigations of dopamine d3 receptor ligands leading to the prediction, synthesis, and evaluation 
of rigidized fauc 365 analogues. Bioorg. Med. Chem. 2006, 14, 5898-5912. 
5.  Heidbreder, C.A.; Gardner, E.L.; Xi, Z.X.; Thanos, P.K.; Mugnaini, M.; Hagan, J.J.;   
Ashby, C.R., Jr. The role of central dopamine d3 receptors in drug addiction: A review of 
pharmacological evidence. Brain Res. Rev. 2005, 49, 77-105. Int. J. Mol. Sci. 2011, 12               
 
 
1218
6.  Wood, M.D.; Boyfield, I.; Nash, D.J.; Jewitt, F.R.; Avenell, K.Y.; Riley, G.J. Evidence for 
antagonist activity of the dopamine d3 receptor partial agonist, bp 897, at human dopamine d3 
receptor. Eur. J. Pharmacol. 2000, 407, 47-51. 
7.  Micheli, F.; Bonanomi, G.; Braggio, S.; Capelli, A.M.; Celestini, P.; Damiani, F.; Di Fabio, R.; 
Donati, D.; Gagliardi, S.; Gentile, G.; Hamprecht, D.; Petrone, M.; Radaelli, S.; Tedesco, G.; 
Terreni, S.; Worby, A.; Heidbreder, C. New fused benzazepine as selective d3 receptor 
antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems. Bioorg. 
Med. Chem. Lett. 2008, 18, 901-907. 
8.  Micheli, F.; Heidbreder, C. Selective dopamine d3 receptor antagonists: A review 2001-2005. 
Recent Pat. CNS Drug Discov. 2006, 1, 271-288. 
9.  Bettinetti, L.; Schlotter, K.; Hubner, H.; Gmeiner, P. Interactive sar studies: Rational discovery of 
super-potent and highly selective dopamine d3 receptor antagonists and partial agonists. J. Med. 
Chem. 2002, 45, 4594-4597. 
10.  Southam, E.; Lloyd, A.; Jennings, C.A.; Cluderay, J.E.; Cilia, J.; Gartlon, J.E.; Jones, D.N. Effect 
of the selective dopamine d3 receptor antagonist sb-277011-a on regional c-fos-like expression in 
rat forebrain. Brain Res. 2007, 1149, 50-57. 
11.  Micheli, F.; Bonanomi, G.; Braggio, S.; Capelli, A.M.; Damiani, F.; Di Fabio, R.; Donati, D.; 
Gentile, G.; Hamprecht, D.; Perini, O.; Petrone, M.; Tedesco, G.; Terreni, S.; Worby, A.; 
Heidbreder, C. New fused benzazepine as selective d3 receptor antagonists. Synthesis and 
biological evaluation. Part 2: [g]-fused and hetero-fused systems. Bioorg. Med. Chem. Lett. 2008, 
18, 908-912. 
12.  Kapetanovic, I.M. Computer-aided drug discovery and development (caddd): In silico-chemico-
biological approach. Chem. Biol. Interact. 2008, 171, 165-176. 
13.  Papa, E.; Battaini, F.; Gramatica, P. Ranking of aquatic toxicity of esters modelled by qsar. 
Chemosphere 2005, 58, 559-570. 
14.  Wang, Z.; Li, Y.; Ai, C.; Wang, Y. In silico prediction of estrogen receptor subtype binding 
affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes 
and 2-arylquinolines. Int. J. Mol. Sci. 2010, 11, 3434-3458. 
15.  Wang, X.; Yang, W.; Xu, X.; Zhang, H.; Li, Y.; Wang, Y. Studies of benzothiadiazine derivatives 
as hepatitis c virus ns5b polymerase inhibitors using 3d-qsar, molecular docking and molecular 
dynamics. Curr. Med. Chem. 2010, 17, 2788-2803. 
16.  Ai, C.; Li, Y.; Wang, Y.; Chen, Y.; Yang, L. Insight into the effects of chiral isomers quinidine 
and quinine on cyp2d6 inhibition. Bioorg. Med. Chem. Lett. 2009, 19, 803-806. 
17.  Ai, C.; Wang, Y.; Li, Y.; Yang, L. A 3-d qsar study of catechol-O-methyltransferase inhibitors 
using comfa and comsia. QSAR Comb. Sci. 2008, 27, 1183-1192. 
18.  Wang, Y.; Li, Y.; Ma, Z.; Yang, W.; Ai, C. Mechanism of microrna-target interaction: Molecular 
dynamics simulations and thermodynamics analysis. PLoS Comput. Biol. 1010, 6, e1000866. 
19.  Hansch, C.; Verma, R.P.; Kurup, A.; Mekapati, S.B. The role of qsar in dopamine interactions. 
Bioorg. Med. Chem. Lett. 2005, 15, 2149-2157. 
20.  Artico, M.; Botta, M.; Corelli, F.; Mai, A.; Massa, S.; Ragno, R. Investigation on qsar and binding 
mode of a new class of human rhinovirus-14 inhibitors by comfa and docking experiments. 
Bioorg. Med. Chem. 1996, 4, 1715-1724. Int. J. Mol. Sci. 2011, 12               
 
 
1219
21.  Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital electronegativity—a rapid access 
to atomic charges. Tetrahedron 1980, 36, 3219-3228. 
22.  Del Re, G.; Pullman, B.; Yonezawa, T. Electronic structure of the [alpha]-amino acids of proteins: 
I. Charge distributions and proton chemical shifts. Biochim. Biophys. Acta 1963, 75, 153-182. 
23. Becker, E.D.; Charney, E.; Anno, T. Molecular vibrations of quinones. Vi. A vibrational 
assignment for p-benzoquinone and six isotopic derivatives. Thermodynamic functions of   
p-benzoquinone. J. Chem. Phys. 1965, 42, 942-949. 
24.  Dixit, A.; Kashaw, S.K.; Gaur, S.; Saxena, A.K. Development of comfa, advance comfa and 
comsia models in pyrroloquinazolines as thrombin receptor antagonist. Bioorg. Med. Chem. 2004, 
12, 3591-3598. 
25.  Golbraikh, A.; Tropsha, A. Beware of q2!. J. Mol. Graph. Model. 2002, 20, 269-276. 
26.  Ashek, A.; Cho, S.J. A combined approach of docking and 3d qsar study of [beta]-ketoacyl-acyl 
carrier protein synthase iii (fabh) inhibitors. Bioorg. Med. Chem. 2006, 14, 1474-1482. 
27.  Gilbert, K.M.; Boos, T.L.; Dersch, C.M.; Greiner, E.; Jacobson, A.E.; Lewis, D.; Matecka, D.; 
Prisinzano, T.E.; Zhang, Y.; Rothman, R.B.; Rice, K.C.; Venanzi, C.A. Dat/sert selectivity of 
flexible gbr 12909 analogs modeled using 3d-qsar methods. Bioorg. Med. Chem.  2007,  15, 
1146-1159. 
28.  Wiese, M.; Pajeva, I.K. Structure-activity relationships of multidrug resistance reversers. Curr. 
Med. Chem. 2001, 8, 685-713. 
29.  Li, Y.; Wang, Y.; Ling,Y.; Zhang, S.; Liu, C. Impact of molecular hydrophobic field on passive 
diffusion, p–glycoprotein active efflux, and p–glycoprotein modulation of steroids. Int. Electron. 
J. Mol. Des. 2006, 5, 60-78. 
30.  Talete srl. Dragon for Windows (Software for Molecular Descriptor Calculations), Version 5.4. 
Available on line: http://www.Talete.Mi.It/ 2006 (accesed on 26 January 2011). 
31. Moriguchi, I.; Hirono, S.; Liu, Q.; Nakagome, Matsushita, Y. Simple method of calculating 
octanol/water partition coefficient. Chem. Pharm. Bull. 1992, 40, 127-130. 
32. Viswanadhan, V.N.; Ghose, A.K.; Revankar, G.R.; Robins, R.K. Atomic physicochemical 
parameters for three dimensional structure directed quantitative structure-activity relationships. 4. 
Additional parameters for hydrophobic and dispersive interactions and their application for an 
automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Comp. 
Sci. 1989, 29, 163-172. 
33.  Cross, S.; Cruciani, G. Molecular fields in drug discovery: Getting old or reaching maturity? Drug 
Discov. Today 2010, 15, 23-32. 
34.  Nayana, M.R.; Sekhar, Y.N.; Nandyala, H.; Muttineni, R.; Bairy, S.K.; Singh, K.; Mahmood, S.K. 
Insight into the structural requirements of proton pump inhibitors based on comfa and comsia 
studies. J. Mol. Graph. Model. 2008, 27, 233-243. 
35.  Austin, N.E.; Avenell, K.Y.; Boyfield, I.; Branch, C.L.; Hadley, M.S.; Jeffrey, P.; Johnson, C.N.; 
Macdonald, G.J.; Nash, D.J.; Riley, G.J.; Smith, A.B.; Stemp, G.; Thewlis, K.M.; Vong, A.K.; 
Wood, M. Novel 2,3,4,5-tetrahydro-1h-3-benzazepines with high affinity and selectivity for the 
dopamine d3 receptor. Bioorg. Med. Chem. Lett. 2000, 10, 2553-2555. 
 Int. J. Mol. Sci. 2011, 12               
 
 
1220
36.  Austin, N.E.; Avenell, K.Y.; Boyfield, I.; Branch, C.L.; Hadley, M.S.; Jeffrey, P.; Johnson, C.N.; 
Macdonald, G.J.; Nash, D.J.; Riley, G.J.; Smith, A.B.; Stemp, G.; Thewlis, K.M.; Vong, A.K.; 
Wood, M.D. Design and synthesis of novel 2,3-dihydro-1h-isoindoles with high affinity and 
selectivity for the dopamine d3 receptor. Bioorg. Med. Chem. Lett. 2001, 11, 685-688. 
37. Maiti, R.; van Domselaar, G.H.; Zhang, H.; Wishart, D.S. Superpose: A simple server for 
sophisticated structural superposition. Nucleic Acids Res. 2004, 32, W590-W594. 
38. Hillisch, A.; Pineda, L.F.; Hilgenfeld, R. Utility of homology models in the drug discovery 
process. Drug Discov. Today 2004, 9, 659-669. 
39.  Boeckler, F.; Lanig, H.; Gmeiner, P. Modeling the similarity and divergence of dopamine d2-like 
receptors and identification of validated ligand-receptor complexes. J. Med. Chem.  2005,  48, 
694-709. 
40. Ortore, G.; Tuccinardi, T.; Bertini, S.; Martinelli, A. A theoretical study to investigate 
d2dar/d4dar selectivity: Receptor modeling and molecular docking of dopaminergic ligands. J. 
Med. Chem. 2006, 49, 1397-1407. 
41.  Varady, J.; Wu, X.; Fang, X.; Min, J.; Hu, Z.; Levant, B.; Wang, S. Molecular modeling of the 
three-dimensional structure of dopamine 3 (d3) subtype receptor: Discovery of novel and potent 
d3 ligands through a hybrid pharmacophore- and structure-based database searching approach.  
J. Med. Chem. 2003, 46, 4377-4392. 
42. Sudandiradoss, C.; George Priya Doss, C.; Rajasekaran, R.; Purohit, R.; Ramanathan, K.; 
Sethumadhavan, R. Analysis of binding residues between scorpion neurotoxins and d2 dopamine 
receptor: A computational docking study. Comput. Biol. Med. 2008, 38, 1056-1067. 
43. Ogata, K.; Umeyama, H. An automatic homology modeling method consisting of database 
searches and simulated annealing. J. Mol. Graph. Model. 2000, 18, 258-272, 305-306. 
44.  Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le Trong, I.; 
Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Crystal structure of 
rhodopsin: A g protein-coupled receptor. Science 2000, 289, 739-745. 
45. Lambert, C.; Leonard, N.; de Bolle, X.; Depiereux, E. Esypred3d: Prediction of proteins 3d 
structures. Bioinformatics. 2002, 18, 1250-1256. 
46.  Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. Procheck: A program to check 
the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-291. 
47.  Fratev, F.; Benfenati, E. A combination of 3d-qsar, docking, local-binding energy (lbe) and grid 
study of the species differences in the carcinogenicity of benzene derivatives chemicals. J. Mol. 
Graph. Model. 2008, 27, 147-160. 
48.  Lv, Y.; Yin, C.; Liu, H.; Yi, Z.; Wang, Y. 3d-qsar study on atmospheric half-lives of pops using 
comfa and comsia. J. Environ. Sci. 2008, 20, 1433-1438. 
49.  Li, Y.; Wang, Y.-H.; Yang, L.; Zhang, S.-W.; Liu, C.-H.; Yang, S.-L. Comparison of steroid 
substrates and inhibitors of p-glycoprotein by 3d-qsar analysis. J. Mol. Struct.  2005,  733, 
111-118. 
50.  Xu, M.; Zhang, A.; Han, S.; Wang, L. Studies of 3d-quantitative structure-activity relationships 
on a set of nitroaromatic compounds: Comfa, advanced comfa and comsia. Chemosphere 2002, 
48, 707-715. Int. J. Mol. Sci. 2011, 12               
 
 
1221
51. Kovalishyn, V.V.; Kholodovych, V.; Tetko, I.V.; Welsh, W.J. Volume learning algorithm 
significantly improved pls model for predicting the estrogenic activity of xenoestrogens. J. Mol. 
Graph. Model. 2007, 26, 591-594. 
52.  Thaimattam, R.; Daga, P.; Rajjak, S.A.; Banerjee, R.; Iqbal, J. 3d-qsar comfa, comsia studies on 
substituted ureas as raf-1 kinase inhibitors and its confirmation with structure-based studies. 
Bioorg. Med. Chem. 2004, 12, 6415-6425. 
53.  Case, D.A.; Cheatham, T.E., III; Darden, T.; Gohlke, H.; Luo, R.; Merz, K.M., Jr.; Onufriev, A.; 
Simmerling, C.; Wang, B.; Woods, R.J. The amber biomolecular simulation programs. J. Comput. 
Chem. 2005, 26, 1668-1688. 
54.  Wang, J.; Wolf, R.M.; Caldwell, J.W.; Kollman, P.A.; Case, D.A. Development and testing of a 
general amber force field. J. Comput. Chem. 2004, 25, 1157-1174. 
55.  Jakalian, A.; Jack, D.B.; Bayly, C.I. Fast, efficient generation of high-quality atomic charges. 
Am1-bcc model: Ii. Parameterization and validation. J. Comput. Chem. 2002, 23, 1623-1641. 
56.  Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M.C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; 
Luo, R.; Lee, T.; Caldwell, J.; Wang, J.; Kollman, P. A point-charge force field for molecular 
mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.  
J. Comput. Chem. 2003, 24, 1999-2012. 
57.  Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H.J.C. Numerical integration of the cartesian equations 
of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 1977, 
23, 327-341. 
58.  Essmann, U.; Perera, L.; Berkowitz, M.L.; Darden, T.; Lee, H.; Pedersen, L.G. A smooth particle 
mesh ewald method. J. Chem. Phys. 1995, 103, 8577-8593. 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 